NM-504

N/A

Report date: 2024/12/03 15:10:08
NME

Base Information

Drug NameNM-504
Drug Alias NameNM-504NM-504 cobioticNM-505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsPrediabetic StateDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMicrobiome Therapeutics Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesNume Health
Active IndicationsPrediabetic State
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A